TLDR Finasteride doesn't change polycystic ovary size or cyst number, suggesting testosterone's role in their appearance.
This study aimed to evaluate the ultrasonographic differences in the ovaries of women with polycystic ovary syndrome (PCOS) after treatment with finasteride, an inhibitor of 5-a-reductase. A total of 31 women with a diagnosis of PCOS were selected to participate in a randomized double-blind controlled trial. The results showed that there were no differences in the volume and number of cysts in the ovaries of women treated with finasteride or those using placebo. This finding may demonstrate that testosterone, rather than DHT, is responsible for the morphology of polycystic ovaries.
27 citations,
July 2009 in “Experimental and Clinical Endocrinology & Diabetes” Finasteride safely reduces excessive hair growth in women.
467 citations,
October 2014 in “European Journal of Endocrinology” The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.
50 citations,
February 2013 in “Annals of Clinical Biochemistry” Understanding how DHT works is important for diagnosing and treating hormone-related disorders.
6 citations,
June 2010 in “Fertility and Sterility” Finasteride helps induce ovulation in nonresponder PCOS women.
24 citations,
January 2013 in “Indian Journal of Dermatology, Venereology and Leprology” Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.
23 citations,
February 2014 in “Journal of Pediatric and Adolescent Gynecology” Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.
18 citations,
June 2010 in “Current medicinal chemistry” Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.